The polymorphic variant −1031 C of TNFA gene confers ACS protection.
T/C+C/C ACS carriers had 2.31 times greater chance of developing dyslipidemia.
Soluble TNF-α levels were higher in ACS than the RG.
T/C carriers showed higher sTNF-α levels compared with T/T homozygotes in ACS.
Serum TNF-α concentration was similar among UA, NSTEMI and STEMI.